Premature Ejaculation & SSRIs
Dapoxetine, Off-Label SSRIs, Topical Anesthetics
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- No oral PE drug FDA-approved in US (dapoxetine declined 2005)
Reference only. Not medical advice.
What can go wrong
Off-label SSRIs carry standard SSRI risks: nausea, fatigue, reduced libido, and in rare cases persistent sexual dysfunction after discontinuation. Dapoxetine is associated with nausea, dizziness, and orthostatic events including syncope. SSRIs must never be combined with MAO inhibitors and require caution with serotonergic agents. Topical anesthetics can transfer to a partner and cause numbness.
This is something to take to a clinician. The Atlas can tell you what is known about premature ejaculation & ssris in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Premature ejaculation (PE) is the most prevalent male sexual dysfunction, often overlapping with erectile dysfunction. The pharmacologic mainstays are serotonergic: dapoxetine, a short-acting SSRI designed for on-demand use, plus off-label chronic SSRIs (paroxetine, sertraline) and topical anesthetics. Dapoxetine is approved in more than 60 countries but the FDA issued a non-approvable letter in 2005, so US treatment remains off-label.
The most common male sexual complaint, and the one with no FDA-approved pill in America.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
Serotonin (5-HT) modulation raises the ejaculatory threshold. Chronic SSRIs delay ejaculation as a side effect harnessed therapeutically. Dapoxetine is a rapidly absorbed and eliminated SSRI (peak ~1 hour, short half-life) engineered for on-demand 1-3 hour pre-coital dosing rather than daily use. Topical lidocaine/prilocaine reduce glans sensitivity directly.
What people get wrong
Often saidPremature ejaculation is purely psychological
ActuallyBoth lifelong and acquired PE have neurobiological components involving serotonergic signaling; behavioral therapy and pharmacology are often combined.
Often saidYou can buy a real PE cure over the counter in the US
ActuallyNo oral PE drug is FDA-approved domestically; OTC 'climax delay' products rely on topical anesthetics, and pills sold online are off-label or unregulated.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
At a glance
- US FDA oral PE drug
- None approved
- Dapoxetine countries
- 60+ (not US)
- IELT goal
- Increase intravaginal ejaculatory latency time
- Off-label SSRIs
- Paroxetine, sertraline, fluoxetine
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Premature Ejaculation & SSRIs. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Dapoxetine pooled phase III RCTs2006
Dapoxetine 30 mg and 60 mg significantly increased IELT versus placebo across thousands of men
FDA non-approvable letter (Alza/J&J)2005
US regulator declined approval; drug later approved across Europe and Asia as Priligy
Paroxetine meta-analysis2004
Paroxetine produced the largest IELT fold-increase among off-label SSRIs